TrialAIDS (London, England)2007

Rosiglitazone increases small dense low-density lipoprotein concentration and decreases high-density lipoprotein particle size in HIV-infected patients.

Colleen Hadigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.